Therefore, the aims of our study were: (i) to dissect whether PEDF and Chemerin are biomarkers of obesity and fat-related inflammation (metaflammation) in RA, influencing disease activity at RA onset. This evidence concerns the gene SERPINF1 and rheumatoid arthritis.